Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,018,024 | 1,589,729 | 5,906,221 | 4,700,436 | 3,377,149 |
| Depreciation Amortization | 326,501 | 161,028 | 600,133 | 356,148 | 240,150 |
| Accounts receivable | N/A | N/A | -400,751 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | 175,223 | N/A | N/A |
| Other Working Capital | -455,716 | -323,882 | 313,292 | -103,428 | 4,323 |
| Other Operating Activity | 865,498 | 78,383 | 227,669 | 850,668 | 474,537 |
| Operating Cash Flow | $3,754,307 | $1,505,258 | $6,821,787 | $5,803,824 | $4,096,159 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -721,525 | -402,417 | -1,471,357 | -1,071,096 | -713,566 |
| Net Acquisitions | -904 | N/A | 56,267 | 57,408 | 58,917 |
| Purchase Of Investment | -7,229 | N/A | -37,919 | -936 | N/A |
| Sale Of Investment | N/A | N/A | 27,216 | 8,892 | 3,362 |
| Purchase Sale Intangibles | -154,365 | -59,815 | -424,145 | -242,268 | -169,546 |
| Other Investing Activity | -152,708 | -58,140 | -421,239 | -239,304 | -167,945 |
| Investing Cash Flow | $-882,365 | $-460,557 | $-1,847,032 | $-1,245,036 | $-819,232 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 14,373 | N/A | N/A |
| Debt Repayment | -65,210 | -54,335 | N/A | N/A | N/A |
| Common Stock Repurchased | -1,133,867 | -448,838 | -2,380,194 | -1,766,076 | -1,240,775 |
| Dividend Paid | -1,853,735 | -1,873,430 | -2,912,439 | -2,971,488 | -1,890,781 |
| Other Financing Activity | -1 | 318,098 | -1 | 0 | 0 |
| Financing Cash Flow | $-3,052,813 | $-2,058,505 | $-5,278,261 | $-4,737,564 | $-3,131,556 |
| Exchange Rate Effect | 2,711 | 11,872 | 6,728 | 8,112 | 12,968 |
| Beginning Cash Position | 2,353,727 | 2,378,734 | 2,623,458 | 2,676,648 | 2,746,996 |
| End Cash Position | 2,175,568 | 1,376,801 | 2,389,674 | 2,505,984 | 2,905,335 |
| Net Cash Flow | $-178,160 | $-1,001,933 | $-233,784 | $-170,664 | $158,339 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,754,307 | 1,505,258 | 6,821,787 | 5,803,824 | 4,096,159 |
| Capital Expenditure | -721,525 | -402,417 | -1,473,344 | -1,072,656 | -713,726 |
| Free Cash Flow | 3,032,782 | 1,102,841 | 5,348,443 | 4,731,168 | 3,382,433 |